U.S. Food and Drug Administration Approves Portola Pharmaceuticals' Prior Approval Supplement for Andexxa® Generation 2 Manufacturing Process - P&T Community

U.S. Food and Drug Administration Approves Portola Pharmaceuticals' Prior Approval Supplement for Andexxa® Generation 2 Manufacturing Process  P&T Community

Expands Patient Access to Andexxa, the First and Only Antidote for Reversal of the Factor Xa Inhibitors Rivaroxaban or Apixaban –. – Full Commercial Launch to ...